Lao People's Democratic Republic vs Saudi Arabia: Share of E. coli infections resistant to cephalosporins
Lao People's Democratic Republic
52.6%
in 2022
Saudi Arabia
52.8%
in 2022
Lao People's Democratic Republic rank
16th
Saudi Arabia rank
15th
Share of E. coli infections resistant to cephalosporins over time
- Lao People's Democratic Republic
- Saudi Arabia
How they compare
Saudi Arabia currently reports 52.8% against 52.6% in Lao People's Democratic Republic, a difference of 0.2%.
Across all 6 years both countries report, Saudi Arabia has been ahead every year.
Lao People's Democratic Republic ranks 16th and Saudi Arabia ranks 15th of 46 countries.
Saudi Arabia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 46.9% | 54.3% | 7.4% | Saudi Arabia |
| 2020s | 49.7% | 54.7% | 5.0% | Saudi Arabia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Lao People's Democratic Republic or Saudi Arabia?
- Saudi Arabia, at 52.8% against 52.6% in Lao People's Democratic Republic as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Lao People's Democratic Republic and Saudi Arabia?
- 0.2%, with Saudi Arabia ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Saudi Arabia?
- 6 years are reported by both, from 2017 to 2022.
- How do Lao People's Democratic Republic and Saudi Arabia rank globally for share of e. coli infections resistant to cephalosporins?
- Lao People's Democratic Republic ranks 16th and Saudi Arabia ranks 15th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).